Company: BLTE
Filing Date: 2025-01-27
Form Type: 424B7
Source: 0001104659-25-006367
Chunk: 1

Company: BELITE BIO, INC
Filing Date: 2025-01-27
Form: 424B7
Chunk 1
---
 compensation in the form of fees or commissions from the selling shareholder and from purchasers of such offered shares for whom they may act as agent. To the extent required, a new prospectus supplement may be filed to set forth the names of any underwriter, agent or broker-dealer and applicable commissions or discounts and any other required information with respect to any particular offer. A new prospectus supplement may also be filed to add, update or change information contained in this prospectus supplement and the accompanying prospectus, including adding the identities of selling shareholders and amounts of ordinary shares to be registered for offer and sale on behalf of selling shareholders. The selling shareholder reserves the sole right to accept or reject, in whole or in part, any proposed purchase of the offered shares to be made directly or through agents. See “Plan of Distribution.”

Investing in the offered shares involves risks. See “Risk Factors” beginning on page S-10of this prospectus supplement and the risks set forth under the caption “Item 3D. Risk Factors” included in our Annual Report on Form 20-F for the year ended December 31, 2023(our “2023 Form 20-F”), which is incorporated by reference herein, and any risk factors described in the other documents that we file pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) after the date of this prospectus supplement and prior to the termination of this offering, which will be considered to be incorporated by reference into this prospectus supplement and the accompanying prospectus.

Neither the United States Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense.**

<div align='center'>The date of this prospectus supplement is January 27, 2025.</div>

TABLE OF CONTENTS

TABLE OF CONTENTS Prospectus Supplement

| ​ | ABOUT THIS PROSPECTUS SUPPLEMENT                     | ​ | ​ | ​ | ​ | S-1  | ​ | ​ |
| ​ | CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | ​ | ​ | ​ | ​ | S-2  | ​ | ​ |
| ​ | PROSPECTUS SUPPLEMENT SUMMARY                        | ​ | ​ | ​ | ​ | S-4  | ​ | ​ |
| ​ | RISK FACTORS                                         |